The Health Resources and Services Administration will pay health care providers who administer authorized COVID-19 vaccines to patients in health plans that do not cover vaccine administration or cover it with patient cost-sharing, the Department of Health and Human Services announced today. The COVID-19 Coverage Assistance Fund will reimburse providers at the national Medicare rate for vaccine administration and related patient charges for eligible claims dated on or after Dec. 14, 2020, subject to available funding through the Provider Relief Fund. The Centers for Medicare & Medicaid Services last month nearly doubled what it pays to administer COVID-19 vaccines to about $40 per dose to better reflect the costs involved and help providers vaccinate more Americans. 

“On top of increasing reimbursement rates tied to administering the shots, we are closing the final payment gap that resulted as vaccines were administered to underinsured individuals,” said HHS Secretary Xavier Becerra. “No healthcare provider should hesitate to deliver these critical vaccines to patients over reimbursement cost concerns.”
 

Related News Articles

Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…
Headline
The Food and Drug Administration Aug. 22 granted emergency use authorization for two new combined COVID-19 and influenza tests. The Nano-Check Influenza-COVID-…